{"id":"https://openalex.org/W4286697628","doi":"https://doi.org/10.3389/fimmu.2022.932298","title":"TIE-2 Signaling Activation by Angiopoietin 2 On Myeloid-Derived Suppressor Cells Promotes Melanoma-Specific T-cell Inhibition","display_name":"TIE-2 Signaling Activation by Angiopoietin 2 On Myeloid-Derived Suppressor Cells Promotes Melanoma-Specific T-cell Inhibition","publication_year":2022,"publication_date":"2022-07-22","ids":{"openalex":"https://openalex.org/W4286697628","doi":"https://doi.org/10.3389/fimmu.2022.932298","pmid":"https://pubmed.ncbi.nlm.nih.gov/35935946","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9353943"},"language":"en","primary_location":{"id":"doi:10.3389/fimmu.2022.932298","doi":"https://doi.org/10.3389/fimmu.2022.932298","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2022.932298","pdf_url":null,"source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.3389/fimmu.2022.932298","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5065534669","display_name":"Am\u00e9lie Marguier","orcid":"https://orcid.org/0000-0002-5649-6688","observed_orcids":["https://orcid.org/0000-0002-5649-6688"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210118524","display_name":"Universit\u00e9 Bourgogne Franche-Comt\u00e9","ror":"https://ror.org/02dn7x778","country_code":"FR","type":"education","lineage":["https://openalex.org/I4210118524"]},{"id":"https://openalex.org/I4405257954","display_name":"Interactions H\u00f4te-Greffon-Tumeur & Ing\u00e9nierie Cellulaire et G\u00e9nique","ror":"https://ror.org/05w3vvc59","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I4210128919","https://openalex.org/I4405256580","https://openalex.org/I4405257954"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Am\u00e9lie Marguier","raw_affiliation_strings":["Univ. Bourgogne Franche-Comt\u00e9, INSERM, EFS BFC, UMR1098, RIGHT Interactions Greffon-H\u00f4te Tumeur/Ing\u00e9nierie Cellulaire et G\u00e9nique, Besan\u00e7on, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ. Bourgogne Franche-Comt\u00e9, INSERM, EFS BFC, UMR1098, RIGHT Interactions Greffon-H\u00f4te Tumeur/Ing\u00e9nierie Cellulaire et G\u00e9nique, Besan\u00e7on, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210118524","https://openalex.org/I4405257954"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019366639","display_name":"Caroline Laheurte","orcid":"https://orcid.org/0000-0002-1364-4556","observed_orcids":["https://orcid.org/0000-0002-1364-4556"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210118524","display_name":"Universit\u00e9 Bourgogne Franche-Comt\u00e9","ror":"https://ror.org/02dn7x778","country_code":"FR","type":"education","lineage":["https://openalex.org/I4210118524"]},{"id":"https://openalex.org/I4405257954","display_name":"Interactions H\u00f4te-Greffon-Tumeur & Ing\u00e9nierie Cellulaire et G\u00e9nique","ror":"https://ror.org/05w3vvc59","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I4210128919","https://openalex.org/I4405256580","https://openalex.org/I4405257954"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Caroline Laheurte","raw_affiliation_strings":["INSERM CIC-1431, Clinical Investigation Center in Biotherapy, Plateforme de Biomonitoring, Besan\u00e7on, France","Univ. Bourgogne Franche-Comt\u00e9, INSERM, EFS BFC, UMR1098, RIGHT Interactions Greffon-H\u00f4te Tumeur/Ing\u00e9nierie Cellulaire et G\u00e9nique, Besan\u00e7on, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM CIC-1431, Clinical Investigation Center in Biotherapy, Plateforme de Biomonitoring, Besan\u00e7on, France","institution_ids":["https://openalex.org/I154526488"]},{"raw_affiliation_string":"Univ. Bourgogne Franche-Comt\u00e9, INSERM, EFS BFC, UMR1098, RIGHT Interactions Greffon-H\u00f4te Tumeur/Ing\u00e9nierie Cellulaire et G\u00e9nique, Besan\u00e7on, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210118524","https://openalex.org/I4405257954"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080693340","display_name":"Beno\u00eet Lecoester","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210118524","display_name":"Universit\u00e9 Bourgogne Franche-Comt\u00e9","ror":"https://ror.org/02dn7x778","country_code":"FR","type":"education","lineage":["https://openalex.org/I4210118524"]},{"id":"https://openalex.org/I4405257954","display_name":"Interactions H\u00f4te-Greffon-Tumeur & Ing\u00e9nierie Cellulaire et G\u00e9nique","ror":"https://ror.org/05w3vvc59","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I4210128919","https://openalex.org/I4405256580","https://openalex.org/I4405257954"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Beno\u00eet Lecoester","raw_affiliation_strings":["Univ. Bourgogne Franche-Comt\u00e9, INSERM, EFS BFC, UMR1098, RIGHT Interactions Greffon-H\u00f4te Tumeur/Ing\u00e9nierie Cellulaire et G\u00e9nique, Besan\u00e7on, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ. Bourgogne Franche-Comt\u00e9, INSERM, EFS BFC, UMR1098, RIGHT Interactions Greffon-H\u00f4te Tumeur/Ing\u00e9nierie Cellulaire et G\u00e9nique, Besan\u00e7on, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210118524","https://openalex.org/I4405257954"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009477556","display_name":"Marine Malfroy","orcid":"https://orcid.org/0009-0005-7013-1668","observed_orcids":["https://orcid.org/0009-0005-7013-1668"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210118524","display_name":"Universit\u00e9 Bourgogne Franche-Comt\u00e9","ror":"https://ror.org/02dn7x778","country_code":"FR","type":"education","lineage":["https://openalex.org/I4210118524"]},{"id":"https://openalex.org/I4405257954","display_name":"Interactions H\u00f4te-Greffon-Tumeur & Ing\u00e9nierie Cellulaire et G\u00e9nique","ror":"https://ror.org/05w3vvc59","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I4210128919","https://openalex.org/I4405256580","https://openalex.org/I4405257954"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Marine Malfroy","raw_affiliation_strings":["Univ. Bourgogne Franche-Comt\u00e9, INSERM, EFS BFC, UMR1098, RIGHT Interactions Greffon-H\u00f4te Tumeur/Ing\u00e9nierie Cellulaire et G\u00e9nique, Besan\u00e7on, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ. Bourgogne Franche-Comt\u00e9, INSERM, EFS BFC, UMR1098, RIGHT Interactions Greffon-H\u00f4te Tumeur/Ing\u00e9nierie Cellulaire et G\u00e9nique, Besan\u00e7on, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210118524","https://openalex.org/I4405257954"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033031556","display_name":"Laura Boullerot","orcid":"https://orcid.org/0000-0002-2029-4742","observed_orcids":["https://orcid.org/0000-0002-2029-4742"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210118524","display_name":"Universit\u00e9 Bourgogne Franche-Comt\u00e9","ror":"https://ror.org/02dn7x778","country_code":"FR","type":"education","lineage":["https://openalex.org/I4210118524"]},{"id":"https://openalex.org/I4405257954","display_name":"Interactions H\u00f4te-Greffon-Tumeur & Ing\u00e9nierie Cellulaire et G\u00e9nique","ror":"https://ror.org/05w3vvc59","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I4210128919","https://openalex.org/I4405256580","https://openalex.org/I4405257954"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Laura Boullerot","raw_affiliation_strings":["INSERM CIC-1431, Clinical Investigation Center in Biotherapy, Plateforme de Biomonitoring, Besan\u00e7on, France","Univ. Bourgogne Franche-Comt\u00e9, INSERM, EFS BFC, UMR1098, RIGHT Interactions Greffon-H\u00f4te Tumeur/Ing\u00e9nierie Cellulaire et G\u00e9nique, Besan\u00e7on, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM CIC-1431, Clinical Investigation Center in Biotherapy, Plateforme de Biomonitoring, Besan\u00e7on, France","institution_ids":["https://openalex.org/I154526488"]},{"raw_affiliation_string":"Univ. Bourgogne Franche-Comt\u00e9, INSERM, EFS BFC, UMR1098, RIGHT Interactions Greffon-H\u00f4te Tumeur/Ing\u00e9nierie Cellulaire et G\u00e9nique, Besan\u00e7on, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210118524","https://openalex.org/I4405257954"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013349517","display_name":"Adeline Renaudin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Adeline Renaudin","raw_affiliation_strings":["INSERM CIC-1431, Clinical Investigation Center in Biotherapy, Plateforme de Biomonitoring, Besan\u00e7on, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM CIC-1431, Clinical Investigation Center in Biotherapy, Plateforme de Biomonitoring, Besan\u00e7on, France","institution_ids":["https://openalex.org/I154526488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067381865","display_name":"Evan Seffar","orcid":"https://orcid.org/0000-0002-2185-5548","observed_orcids":["https://orcid.org/0000-0002-2185-5548"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210118524","display_name":"Universit\u00e9 Bourgogne Franche-Comt\u00e9","ror":"https://ror.org/02dn7x778","country_code":"FR","type":"education","lineage":["https://openalex.org/I4210118524"]},{"id":"https://openalex.org/I4405257954","display_name":"Interactions H\u00f4te-Greffon-Tumeur & Ing\u00e9nierie Cellulaire et G\u00e9nique","ror":"https://ror.org/05w3vvc59","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I4210128919","https://openalex.org/I4405256580","https://openalex.org/I4405257954"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Evan Seffar","raw_affiliation_strings":["Univ. Bourgogne Franche-Comt\u00e9, INSERM, EFS BFC, UMR1098, RIGHT Interactions Greffon-H\u00f4te Tumeur/Ing\u00e9nierie Cellulaire et G\u00e9nique, Besan\u00e7on, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ. Bourgogne Franche-Comt\u00e9, INSERM, EFS BFC, UMR1098, RIGHT Interactions Greffon-H\u00f4te Tumeur/Ing\u00e9nierie Cellulaire et G\u00e9nique, Besan\u00e7on, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210118524","https://openalex.org/I4405257954"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090799329","display_name":"Abhishek Kumar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210118524","display_name":"Universit\u00e9 Bourgogne Franche-Comt\u00e9","ror":"https://ror.org/02dn7x778","country_code":"FR","type":"education","lineage":["https://openalex.org/I4210118524"]},{"id":"https://openalex.org/I4405257954","display_name":"Interactions H\u00f4te-Greffon-Tumeur & Ing\u00e9nierie Cellulaire et G\u00e9nique","ror":"https://ror.org/05w3vvc59","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I4210128919","https://openalex.org/I4405256580","https://openalex.org/I4405257954"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Abhishek Kumar","raw_affiliation_strings":["Univ. Bourgogne Franche-Comt\u00e9, INSERM, EFS BFC, UMR1098, RIGHT Interactions Greffon-H\u00f4te Tumeur/Ing\u00e9nierie Cellulaire et G\u00e9nique, Besan\u00e7on, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ. Bourgogne Franche-Comt\u00e9, INSERM, EFS BFC, UMR1098, RIGHT Interactions Greffon-H\u00f4te Tumeur/Ing\u00e9nierie Cellulaire et G\u00e9nique, Besan\u00e7on, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210118524","https://openalex.org/I4405257954"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010050124","display_name":"Charl\u00e9e Nardin","orcid":"https://orcid.org/0000-0002-9902-5990","observed_orcids":["https://orcid.org/0000-0002-9902-5990"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210087978","display_name":"Centre Hospitalier Universitaire de Besan\u00e7on","ror":"https://ror.org/0084te143","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210087978"]},{"id":"https://openalex.org/I4210118524","display_name":"Universit\u00e9 Bourgogne Franche-Comt\u00e9","ror":"https://ror.org/02dn7x778","country_code":"FR","type":"education","lineage":["https://openalex.org/I4210118524"]},{"id":"https://openalex.org/I4405257954","display_name":"Interactions H\u00f4te-Greffon-Tumeur & Ing\u00e9nierie Cellulaire et G\u00e9nique","ror":"https://ror.org/05w3vvc59","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I4210128919","https://openalex.org/I4405256580","https://openalex.org/I4405257954"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Charl\u00e9e Nardin","raw_affiliation_strings":["Department of Dermatology, University Hospital of Besan\u00e7on, Besan\u00e7on, France","Univ. Bourgogne Franche-Comt\u00e9, INSERM, EFS BFC, UMR1098, RIGHT Interactions Greffon-H\u00f4te Tumeur/Ing\u00e9nierie Cellulaire et G\u00e9nique, Besan\u00e7on, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, University Hospital of Besan\u00e7on, Besan\u00e7on, France","institution_ids":["https://openalex.org/I4210087978"]},{"raw_affiliation_string":"Univ. Bourgogne Franche-Comt\u00e9, INSERM, EFS BFC, UMR1098, RIGHT Interactions Greffon-H\u00f4te Tumeur/Ing\u00e9nierie Cellulaire et G\u00e9nique, Besan\u00e7on, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210118524","https://openalex.org/I4405257954"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044024585","display_name":"Fran\u00e7ois Aubin","orcid":"https://orcid.org/0000-0002-1421-4996","observed_orcids":["https://orcid.org/0000-0002-1421-4996","https://orcid.org/0000-0002-8241-4156","https://orcid.org/0000-0003-3171-8974"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210087978","display_name":"Centre Hospitalier Universitaire de Besan\u00e7on","ror":"https://ror.org/0084te143","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210087978"]},{"id":"https://openalex.org/I4210118524","display_name":"Universit\u00e9 Bourgogne Franche-Comt\u00e9","ror":"https://ror.org/02dn7x778","country_code":"FR","type":"education","lineage":["https://openalex.org/I4210118524"]},{"id":"https://openalex.org/I4405257954","display_name":"Interactions H\u00f4te-Greffon-Tumeur & Ing\u00e9nierie Cellulaire et G\u00e9nique","ror":"https://ror.org/05w3vvc59","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I4210128919","https://openalex.org/I4405256580","https://openalex.org/I4405257954"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Fran\u00e7ois Aubin","raw_affiliation_strings":["Department of Dermatology, University Hospital of Besan\u00e7on, Besan\u00e7on, France","Univ. Bourgogne Franche-Comt\u00e9, INSERM, EFS BFC, UMR1098, RIGHT Interactions Greffon-H\u00f4te Tumeur/Ing\u00e9nierie Cellulaire et G\u00e9nique, Besan\u00e7on, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, University Hospital of Besan\u00e7on, Besan\u00e7on, France","institution_ids":["https://openalex.org/I4210087978"]},{"raw_affiliation_string":"Univ. Bourgogne Franche-Comt\u00e9, INSERM, EFS BFC, UMR1098, RIGHT Interactions Greffon-H\u00f4te Tumeur/Ing\u00e9nierie Cellulaire et G\u00e9nique, Besan\u00e7on, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210118524","https://openalex.org/I4405257954"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5060518732","display_name":"Olivier Adot\u00e9vi","orcid":"https://orcid.org/0000-0002-7742-136X","observed_orcids":["https://orcid.org/0000-0002-7742-136X"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210087978","display_name":"Centre Hospitalier Universitaire de Besan\u00e7on","ror":"https://ror.org/0084te143","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210087978"]},{"id":"https://openalex.org/I4210118524","display_name":"Universit\u00e9 Bourgogne Franche-Comt\u00e9","ror":"https://ror.org/02dn7x778","country_code":"FR","type":"education","lineage":["https://openalex.org/I4210118524"]},{"id":"https://openalex.org/I4405257954","display_name":"Interactions H\u00f4te-Greffon-Tumeur & Ing\u00e9nierie Cellulaire et G\u00e9nique","ror":"https://ror.org/05w3vvc59","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I4210128919","https://openalex.org/I4405256580","https://openalex.org/I4405257954"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Olivier Adotevi","raw_affiliation_strings":["INSERM CIC-1431, Clinical Investigation Center in Biotherapy, Plateforme de Biomonitoring, Besan\u00e7on, France","Service Oncologie m\u00e9dicale, CHU Besan\u00e7on, Besan\u00e7on, France","Univ. Bourgogne Franche-Comt\u00e9, INSERM, EFS BFC, UMR1098, RIGHT Interactions Greffon-H\u00f4te Tumeur/Ing\u00e9nierie Cellulaire et G\u00e9nique, Besan\u00e7on, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM CIC-1431, Clinical Investigation Center in Biotherapy, Plateforme de Biomonitoring, Besan\u00e7on, France","institution_ids":["https://openalex.org/I154526488"]},{"raw_affiliation_string":"Service Oncologie m\u00e9dicale, CHU Besan\u00e7on, Besan\u00e7on, France","institution_ids":["https://openalex.org/I4210087978"]},{"raw_affiliation_string":"Univ. Bourgogne Franche-Comt\u00e9, INSERM, EFS BFC, UMR1098, RIGHT Interactions Greffon-H\u00f4te Tumeur/Ing\u00e9nierie Cellulaire et G\u00e9nique, Besan\u00e7on, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210118524","https://openalex.org/I4405257954"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5060518732"],"corresponding_institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210087978","https://openalex.org/I4210118524","https://openalex.org/I4405257954"],"apc_list":{"value":2950,"currency":"USD","value_usd":2950},"apc_paid":{"value":2950,"currency":"USD","value_usd":2950},"fwci":1.3101,"has_fulltext":true,"cited_by_count":21,"citation_normalized_percentile":{"value":0.77029047,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":96,"max":99},"biblio":{"volume":"13","issue":null,"first_page":"932298","last_page":"932298"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/myeloid-derived-suppressor-cells","display_name":"myeloid-derived suppressor cells","score":0.9300000071525574},{"id":"https://openalex.org/keywords/angiopoietin-2","display_name":"angiopoietin-2","score":0.9990000128746033},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.9909999966621399},{"id":"https://openalex.org/keywords/t-cell-suppression","display_name":"T cell suppression","score":0.6169999837875366},{"id":"https://openalex.org/keywords/immune-evasion","display_name":"immune evasion","score":0.6340000033378601},{"id":"https://openalex.org/keywords/arginase-1","display_name":"arginase-1","score":0.8489999771118164},{"id":"https://openalex.org/keywords/pd-l1","display_name":"PD-L1","score":0.9150000214576721},{"id":"https://openalex.org/keywords/cd73","display_name":"CD73","score":0.8130000233650208},{"id":"https://openalex.org/keywords/transforming-growth-factor-beta","display_name":"TGF-beta","score":0.8930000066757202},{"id":"https://openalex.org/keywords/il-10","display_name":"IL-10","score":0.9890000224113464},{"id":"https://openalex.org/keywords/regorafenib","display_name":"regorafenib","score":0.8640000224113464},{"id":"https://openalex.org/keywords/rebastinib","display_name":"rebastinib","score":0.996999979019165},{"id":"https://openalex.org/keywords/tumor-immunosuppression","display_name":"tumor immunosuppression","score":0.7139999866485596}],"concepts":[{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.7137253284454346},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6645843386650085},{"id":"https://openalex.org/C55721878","wikidata":"https://www.wikidata.org/wiki/Q15220362","display_name":"Myeloid-derived Suppressor Cell","level":4,"score":0.6542782783508301},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.6328794956207275},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.4575177729129791},{"id":"https://openalex.org/C179185449","wikidata":"https://www.wikidata.org/wiki/Q219699","display_name":"Suppressor","level":3,"score":0.4380342960357666},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4176437258720398},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.41697028279304504},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4115787148475647},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3715471625328064},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3618636727333069},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.10271432995796204},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000072737","descriptor_name":"Myeloid-Derived Suppressor Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D042702","descriptor_name":"Angiopoietin-2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.3389/fimmu.2022.932298","doi":"https://doi.org/10.3389/fimmu.2022.932298","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2022.932298","pdf_url":null,"source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9353943","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9353943/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9353943/pdf/","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Immunol","raw_type":"Text"},{"id":"pmid:35935946","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35935946","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in immunology","raw_type":"Journal Article"},{"id":"pmh:oai:HAL:hal-05750195v1","doi":null,"is_oa":false,"landing_page_url":"https://hal.science/hal-05750195","pdf_url":null,"source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Immunology, 2022, 13, ⟨10.3389/fimmu.2022.932298⟩","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:doaj.org/article:4ad89da152d74e058957e595e319c057","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/4ad89da152d74e058957e595e319c057","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Immunology, Vol 13 (2022)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fimmu.2022.932298","doi":"https://doi.org/10.3389/fimmu.2022.932298","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2022.932298","pdf_url":null,"source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320322363","display_name":"Ligue Contre le Cancer","ror":"https://ror.org/00rkrv905"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4286697628.pdf","grobid_xml":"https://content.openalex.org/works/W4286697628.grobid-xml"},"referenced_works_count":48,"referenced_works":["https://openalex.org/W12963118","https://openalex.org/W1577847722","https://openalex.org/W1927075449","https://openalex.org/W1970400427","https://openalex.org/W1977587080","https://openalex.org/W1985102142","https://openalex.org/W1985317418","https://openalex.org/W1999995687","https://openalex.org/W2009891045","https://openalex.org/W2021955841","https://openalex.org/W2024608904","https://openalex.org/W2030729823","https://openalex.org/W2054919355","https://openalex.org/W2054957750","https://openalex.org/W2120621109","https://openalex.org/W2124109795","https://openalex.org/W2125763124","https://openalex.org/W2128102844","https://openalex.org/W2133498548","https://openalex.org/W2149360266","https://openalex.org/W2150487692","https://openalex.org/W2157483153","https://openalex.org/W2157578187","https://openalex.org/W2163825883","https://openalex.org/W2266683146","https://openalex.org/W2290042657","https://openalex.org/W2338773006","https://openalex.org/W2471500324","https://openalex.org/W2568946517","https://openalex.org/W2595056484","https://openalex.org/W2605835842","https://openalex.org/W2738118286","https://openalex.org/W2745510155","https://openalex.org/W2755839425","https://openalex.org/W2770010368","https://openalex.org/W2782485041","https://openalex.org/W2783633531","https://openalex.org/W2810645630","https://openalex.org/W2915483217","https://openalex.org/W2995329111","https://openalex.org/W3013534758","https://openalex.org/W3017218538","https://openalex.org/W3028987787","https://openalex.org/W3117863408","https://openalex.org/W3133863984","https://openalex.org/W3190141506","https://openalex.org/W3212335792","https://openalex.org/W6600535977"],"related_works":["https://openalex.org/W4386040840","https://openalex.org/W4408566951","https://openalex.org/W4414702188","https://openalex.org/W7151836583","https://openalex.org/W2157483153","https://openalex.org/W2108012025","https://openalex.org/W4366817320","https://openalex.org/W2181078066","https://openalex.org/W3017218538","https://openalex.org/W2286776333"],"abstract_inverted_index":{"Myeloid-derived":[0],"suppressor":[1],"cells":[2,11,118,205],"(MDSCs)":[3],"are":[4],"a":[5,29,56,110,135,219],"heterogeneous":[6],"group":[7],"of":[8,28,32,60,75,90,116,124,126,138,147,165,170,203],"immune":[9,25,99,221],"suppressive":[10,26,100,201],"detected":[12],"in":[13,65,142,158,224],"several":[14],"human":[15],"cancers.":[16],"In":[17],"this":[18],"study,":[19],"we":[20,133,190],"investigated":[21],"the":[22,40,43,76,82,87,122,163,168],"features":[23],"and":[24,107],"function":[27],"novel":[30],"subset":[31],"monocytic":[33],"MDSC":[34],"overexpressing":[35],"TIE-2":[36,61,77,92,148,171,182,195,214],"(TIE-2":[37],"+":[38,62,78,93,149,172,215],"M-MDSC),":[39],"receptor":[41],"for":[42,199],"pro-angiogenic":[44],"factor":[45],"angiopoietin":[46],"2":[47],"(ANGPT2).":[48],"We":[49],"showed":[50],"that":[51,162,192,213],"patients":[52,97,143],"with":[53,86,152],"melanoma":[54,83,96],"exhibited":[55],"higher":[57],"circulating":[58],"rate":[59,80],"M-MDSCs,":[63],"especially":[64],"advanced":[66],"stages,":[67],"as":[68,103,186],"compared":[69],"to":[70,119,174],"healthy":[71],"donors.":[72],"The":[73,114],"distribution":[74],"M-MDSC":[79,94,150,173],"toward":[81],"stage":[84],"correlated":[85],"serum":[88],"level":[89],"ANGPT2.":[91,153],"from":[95],"overexpressed":[98],"molecules":[101],"such":[102,185],"PD-L1,":[104],"CD73,":[105],"TGF-\u03b2,":[106],"IL-10,":[108],"suggesting":[109],"highly":[111],"immunosuppressive":[112],"phenotype.":[113],"exposition":[115],"these":[117,127,204,210],"ANGPT2":[120,166,207],"increased":[121,167],"expression":[123],"most":[125],"molecules,":[128],"mainly":[129],"Arginase":[130],"1.":[131],"Hence,":[132],"observed":[134],"profound":[136],"impairment":[137],"melanoma-specific":[139],"T-cell":[140,177],"responses":[141],"harboring":[144],"high":[145],"levels":[146],"along":[151],"This":[154],"was":[155,197],"confirmed":[156],"by":[157,180],"vitro":[159],"experiments":[160],"indicating":[161],"addition":[164],"ability":[169],"suppress":[175],"antitumor":[176],"function.":[178],"Furthermore,":[179],"using":[181],"kinase-specific":[183],"inhibitors":[184],"regorafenib":[187],"or":[188],"rebastinib,":[189],"demonstrated":[191],"an":[193],"active":[194],"signaling":[196],"required":[198],"optimal":[200],"activity":[202],"after":[206],"exposition.":[208],"Collectively,":[209],"results":[211],"support":[212],"M-MDSC/ANGPT2":[216],"axis":[217],"represents":[218],"potential":[220],"escape":[222],"mechanism":[223],"melanoma.":[225]},"counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":4}],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2022-07-23T00:00:00"}